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S242 Poster Session Iand mortality after allogeneic hematopoietic stem cell transplanta-
tion. However very little is known about pulmonary dysfunction
following myeloablative umbilical cord blood transplantation
(CBT).
Methods: We performed a retrospective analysis of data prospec-
tively collected between January 2006 and December 2009 from pa-
tients who underwent double CBT following myeloablative
conditioning with total body irradiation (1320 cGy), cyclophospha-
mide (60 mg/kg iv daily for 2 days) and fludarabine (40 mg/m2 iv
daily for 3 days). Pulmonary function tests (PFTs) were performed
pretransplant and at day 80 and 1 year after transplantation. Lung
function score (LFS) categories were calculated by combining
FEV1 and DLCO and categorized 0 5 normal, 1 5 mildly abnor-
mal, 25moderately abnormal and 35 severely abnormal as defined
by NIH recommendations.
Results:Of 49 patients, 13 (26%) were excluded because either died
prior to or were without day 80 PFTs and 3 (6%) due to lack of pre-
transplant PFTs. Thirty three patients (68%) were included in the
final analysis. The median age and follow-up were 24.2 years (IQR
15.2-38) and 789 days (IQR 335-1087), respectively. Twenty-three
(70%) patients had PFTs at 1 year. Table 1 shows both the distribu-
tion and changes of the PFT data collected at day 80 and 1 year after
transplantation. At 1 year 60% of patients were in LFS category 1
and no one in category 3. The rate of lung function decline (ex-
pressed as the annualized rate of FEV1 decline) from baseline to 1
year after CBT was \ 5% in 78% patients. Four (12%) patients
had abnormal PFTs with an obstructive pattern (AFO) in 3 (9%)
and a restrictive pattern (RP) in one (3%). In 2 of the 3 patients
with obstruction, the obstructive pattern resolved after corticoste-
roid therapy.
Conclusions: To our knowledge this is the first study to describe
pulmonary function after double CBT. No clinically significant de-
creases in all PFTs during the first year were observed. In partic-
ular the majority of patients presented a minimal rate of FEV1
decline. The incidence of AFO and RP was lower than that usually
observed after transplantation from unrelated donors. Future con-
firmatory studies should include more patients and a comparison
group.
Table 1. Comparison of change in pulmonary function
parameters obtained pretransplant, at day 80, and one year
after transplant.
FEV1 FVC FEV/FVC TLC DLcoMean value of PFTs:Pretransplant 91.4 ± 12.8 97.5 ± 14.4 0.81 ± 0.12 97.9 ± 12.8 75.7 ± 13.1Day 80 86.0 ± 12.9 91.7 ± 12.2 0.79 ± 0.08 94.7 ± 12.0 71.1 ± 16.21 year 88.6 ± 11.3 91.7 ± 15.1 0.84 ± 0.08 92.9 ± 12.5 70.1 ± 18.9Mean Change of PFTs:Day 80 -6.4 ± 11.3 -6.9 ± 11.3 -1.8 ± 5.7 -4.3 ± 6.6 -5.3 ± 11.81 year -3.6 ± 10.7 -3.0 ± 11.2 0.4 ± 8.6 -2.2 ± 10.1 -7.4 ± 14.3239
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Introduction:Radiation induced cavernous hemangioma (RICH) is
a late complication of cerebral radiation therapy. An increased num-
ber of long term surviving blood and marrow transplantation (BMT)
recipients have recovered from their primary diseases but are at risk
of RICH.
Methods:We investigated 67 patients who underwent BMT during
childhood or adolescence. We evaluated RICH numbers, size, loca-
tion and their annual changes. Furthermore we developed scoringsystem of RICH in order to classify the severity. MRI of the brain
was performed annually for 5 to 27 years after BMT, including gra-
dient-echo sequence (T2* weighted image). RICH SCORE 1-4 is
designated as mild, 5-9 as moderate and 10 or more as severe.
Results: Twenty-six patients (38.8%) was diagnosed RICH. All
cases received TBI as conditioning of BMT and/or cranial radiation
(CR) prior to BMTas treatment of primary disease. RICHwas found
in 26/48 (54.2%) who received TBI and/or CR, and was not found in
any of 19 patients without radiation therapy to the brain. Total dose
to the brain was 10-36Gy. RICH SCORE ranged 1-18 points (me-
dian 4 points). Small RICHs tended to be recognized only by T2*
weighted image, but not by routine imagingmethods. Classifications
of the severity were mild in 14 patients, moderate in 8 patients and
severe in 4 patients. Severity was correlated with higher radiation
dose and/or with younger ages at transplantation. One case
developed giant RICH more than 40mm.
Conclusion: Since all of those patients did not show RICH before
BMT and all positive patients had a history of radiation therapy to
the brain, the cause of RICH in those patients was considered to
be radiation. Careful and long term evaluation with MRI including
T2* weighted image is necessary in BMT recipients who received
radiation therapy prior and/or during BMT.240
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Previously we reported a retrospective study describing the posi-
tive impact of having an inpatient lay care-partner (CP) on patient
survival in allogeneic BMT. To better explain this phenomenon
we launched a prospective study comparing illness adjustment be-
tween allo BMTpatients with andwithout an inpatient lay CP. Study
patients were a subset of acute leukemia patients from a larger pro-
spective study (N5 164) that verified patients with a CP had signif-
icantly better rates of survival (P 5 0.017). Of the 32 enrolled
patients, 17 had a CP; 15 did not. Utilizing a modes of illness adjust-
ment (MIA) interview schedule, patients were interviewed pre-ad-
mission and 100 days post-transplant by a social worker; taped
interviews were scored by two other social workers. The Psychoso-
cial Assessment of Candidate for Transplant (PACT) Scale was com-
pleted by the social worker. Patients completed FACT-BMT
(quality of life), Profile of Mood States-Short Form (POMS), and
Brief COPE.
Majority of CPs were female, a spouse or parent, and were with
patients a median of 7 hours a day and a median of 85% of inpa-
tient days. There were no significant differences between patients
with and without CPs on patient demographics and medical vari-
ables. Patients with a CP had significantly better scores on the ini-
tial PACT scale rating of candidate quality for transplant (P 5
0.022) and on sub-scale of family or support system availability
(P 5 # 0.001).
Illness adjustment included four modes: accommodation, second-
ary gains, denial, resignation, and two summed variables: accommo-
dation1 secondary gains and denial1 resignation. Variables did not
differ significantly between groups at baseline, although at post-
transplant resignation (P 5 0.009) and denial 1 resignation (P 5
0.036) were significantly smaller among patients with no CP. Also,
from pre- to post-transplant, denial (P 5 0.049) and denial1 resig-
nation (P5 0.044) decreased among patients without a CP, suggest-
ing these patients may have become less oppositional in adjusting to
illness.
MIA did not correlate significantly with patient survival but sur-
vival correlated significantly with CP presence (P 5 0.039) and CP
frequency. 75% (P5 0.019). MIA correlated significantly with se-
lect items on FACT-BMT, POMS, and Brief COPE. Better scores
on these scales associated with complimentaryMIA and worse scores
associated with oppositional MIA. Essential is a support program for
patients as well as CPs to improve quality and outcome of the BMT
experience.
